241 related articles for article (PubMed ID: 31918727)
1. Longitudinal within-host evolution of HIV Nef-mediated CD4, HLA and SERINC5 downregulation activity: a case study.
Sudderuddin H; Kinloch NN; Jin SW; Miller RL; Jones BR; Brumme CJ; Joy JB; Brockman MA; Brumme ZL
Retrovirology; 2020 Jan; 17(1):3. PubMed ID: 31918727
[TBL] [Abstract][Full Text] [Related]
2. Natural HIV-1 Nef Polymorphisms Impair SERINC5 Downregulation Activity.
Jin SW; Alsahafi N; Kuang XT; Swann SA; Toyoda M; Göttlinger H; Walker BD; Ueno T; Finzi A; Brumme ZL; Brockman MA
Cell Rep; 2019 Nov; 29(6):1449-1457.e5. PubMed ID: 31693887
[TBL] [Abstract][Full Text] [Related]
3. An Amino Acid Polymorphism within the HIV-1 Nef Dileucine Motif Functionally Uncouples Cell Surface CD4 and SERINC5 Downregulation.
Mumby MJ; Johnson AL; Trothen SM; Edgar CR; Gibson R; Stathopulos PB; Arts EJ; Dikeakos JD
J Virol; 2021 Jul; 95(16):e0058821. PubMed ID: 34037423
[TBL] [Abstract][Full Text] [Related]
4. The Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor.
Trautz B; Pierini V; Wombacher R; Stolp B; Chase AJ; Pizzato M; Fackler OT
J Virol; 2016 Dec; 90(23):10915-10927. PubMed ID: 27681140
[TBL] [Abstract][Full Text] [Related]
5. Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes.
Mann JK; Byakwaga H; Kuang XT; Le AQ; Brumme CJ; Mwimanzi P; Omarjee S; Martin E; Lee GQ; Baraki B; Danroth R; McCloskey R; Muzoora C; Bangsberg DR; Hunt PW; Goulder PJ; Walker BD; Harrigan PR; Martin JN; Ndung'u T; Brockman MA; Brumme ZL
Retrovirology; 2013 Sep; 10():100. PubMed ID: 24041011
[TBL] [Abstract][Full Text] [Related]
6. Impaired ability of Nef to counteract SERINC5 is associated with reduced plasma viremia in HIV-infected individuals.
Toyoda M; Kamori D; Tan TS; Goebuchi K; Ohashi J; Carlson J; Kawana-Tachikawa A; Gatanaga H; Oka S; Pizzato M; Ueno T
Sci Rep; 2020 Nov; 10(1):19416. PubMed ID: 33173092
[TBL] [Abstract][Full Text] [Related]
7. Resistance of Major Histocompatibility Complex Class B (MHC-B) to Nef-Mediated Downregulation Relative to that of MHC-A Is Conserved among Primate Lentiviruses and Influences Antiviral T Cell Responses in HIV-1-Infected Individuals.
Mwimanzi F; Toyoda M; Mahiti M; Mann JK; Martin JN; Bangsberg D; Brockman MA; Goulder P; Kirchhoff F; Brumme ZL; Ndung'u T; Ueno T
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046444
[TBL] [Abstract][Full Text] [Related]
8. Relative Resistance of HLA-B to Downregulation by Naturally Occurring HIV-1 Nef Sequences.
Mahiti M; Toyoda M; Jia X; Kuang XT; Mwimanzi F; Mwimanzi P; Walker BD; Xiong Y; Brumme ZL; Brockman MA; Ueno T
mBio; 2016 Jan; 7(1):e01516-15. PubMed ID: 26787826
[TBL] [Abstract][Full Text] [Related]
9. Potent Enhancement of HIV-1 Replication by Nef in the Absence of SERINC3 and SERINC5.
Wu Y; Olety B; Weiss ER; Popova E; Yamanaka H; Göttlinger H
mBio; 2019 Jun; 10(3):. PubMed ID: 31186327
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 Nef Antagonizes SERINC5 Restriction by Downregulation of SERINC5 via the Endosome/Lysosome System.
Shi J; Xiong R; Zhou T; Su P; Zhang X; Qiu X; Li H; Li S; Yu C; Wang B; Ding C; Smithgall TE; Zheng YH
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514909
[TBL] [Abstract][Full Text] [Related]
11. Differential Ability of Primary HIV-1 Nef Isolates To Downregulate HIV-1 Entry Receptors.
Toyoda M; Ogata Y; Mahiti M; Maeda Y; Kuang XT; Miura T; Jessen H; Walker BD; Brockman MA; Brumme ZL; Ueno T
J Virol; 2015 Sep; 89(18):9639-52. PubMed ID: 26178998
[TBL] [Abstract][Full Text] [Related]
12. An HIV-1 Nef genotype that diminishes immune control mediated by protective human leucocyte antigen alleles.
Mwimanzi F; Ngare I; Toyoda M; Mori M; Mann J; Ndung'u T; Goulder P; Ueno T
AIDS; 2020 Jul; 34(9):1325-1330. PubMed ID: 32590431
[TBL] [Abstract][Full Text] [Related]
13. HIV Subtype and Nef-Mediated Immune Evasion Function Correlate with Viral Reservoir Size in Early-Treated Individuals.
Omondi FH; Chandrarathna S; Mujib S; Brumme CJ; Jin SW; Sudderuddin H; Miller RL; Rahimi A; Laeyendecker O; Bonner P; Yue FY; Benko E; Kovacs CM; Brockman MA; Ostrowski M; Brumme ZL
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602611
[TBL] [Abstract][Full Text] [Related]
14. Maintenance of AP-2-Dependent Functional Activities of Nef Restricts Pathways of Immune Escape from CD8 T Lymphocyte Responses.
Schouest B; Weiler AM; Janaka SK; Myers TA; Das A; Wilder SC; Furlott J; Baddoo M; Flemington EK; Rakasz EG; Evans DT; Friedrich TC; Maness NJ
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237831
[TBL] [Abstract][Full Text] [Related]
15. Primary HIV-1 Strains Use Nef To Downmodulate HLA-E Surface Expression.
van Stigt Thans T; Akko JI; Niehrs A; Garcia-Beltran WF; Richert L; Stürzel CM; Ford CT; Li H; Ochsenbauer C; Kappes JC; Hahn BH; Kirchhoff F; Martrus G; Sauter D; Altfeld M; Hölzemer A
J Virol; 2019 Oct; 93(20):. PubMed ID: 31375574
[TBL] [Abstract][Full Text] [Related]
16. Impaired Nef function is associated with early control of HIV-1 viremia.
Kuang XT; Li X; Anmole G; Mwimanzi P; Shahid A; Le AQ; Chong L; Qian H; Miura T; Markle T; Baraki B; Connick E; Daar ES; Jessen H; Kelleher AD; Little S; Markowitz M; Pereyra F; Rosenberg ES; Walker BD; Ueno T; Brumme ZL; Brockman MA
J Virol; 2014 Sep; 88(17):10200-13. PubMed ID: 24965469
[TBL] [Abstract][Full Text] [Related]
17. A Conserved Acidic Residue in the C-Terminal Flexible Loop of HIV-1 Nef Contributes to the Activity of SERINC5 and CD4 Downregulation.
Firrito C; Bertelli C; Rosa A; Chande A; Ananth S; van Dijk H; Fackler OT; Stoneham C; Singh R; Guatelli J; Pizzato M
Viruses; 2023 Feb; 15(3):. PubMed ID: 36992361
[TBL] [Abstract][Full Text] [Related]
18. AP-2 Adaptor Complex-Dependent Enhancement of HIV-1 Replication by Nef in the Absence of the Nef/AP-2 Targets SERINC5 and CD4.
Olety B; Usami Y; Wu Y; Peters P; Göttlinger H
mBio; 2023 Feb; 14(1):e0338222. PubMed ID: 36622146
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 subtype C Nef-mediated SERINC5 down-regulation significantly contributes to overall Nef activity.
Naicker D; Sonela N; Jin SW; Mulaudzi T; Ojwach D; Reddy T; Brockman MA; Brumme ZL; Ndung'u T; Mann JK
Retrovirology; 2023 Mar; 20(1):3. PubMed ID: 37004071
[TBL] [Abstract][Full Text] [Related]
20. SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.
Usami Y; Wu Y; Göttlinger HG
Nature; 2015 Oct; 526(7572):218-23. PubMed ID: 26416733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
